AI assistant
Sending…
Capstone Holding Corp. — Director's Dealing 2014
Jan 2, 2014
35323_dirs_2014-01-02_fb909745-640b-4cdd-94ab-58ba29246f77.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2014-01-01
Reporting Person: HOLLIMAN JOHN M III (Director, Executive Chairman)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-01-01 | Stock Option (Right to Buy) | $0.26 | A | 10000 | Acquired | 2024-01-01 | Common Stock (10000) | Direct |
More from Capstone Holding Corp.
Interim / Quarterly Report
2026
May 20
Proxy Solicitation & Information Statement
2026
May 8
Annual Report
2026
May 7
Proxy Solicitation & Information Statement
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Apr 23
Annual Report
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Apr 16